A Multiple Ascending Dose Study of ETC-1002 in Subjects With Mild Dyslipidemia

Inclusion Criteria: * Healthy male and female subjects of non-child bearing potential as determined by medical history, physical examination, vital signs, ECG, and clinical laboratory measurements * Fasting low density lipoprotein-cholesterol (LDL-C) of 100-160 mg/dL * Fasting triglycerides (TG) of 100-350 mg/dL (Cohort 5 only) * Body Mass Index (BMI) of 18-32 kg/m2 (Cohort 1 to 4 only) or 18-36 (Cohort 5 only) and body weight \>50 kg Exclusion Criteria: * Clinically significant disease that requires a physician's care and/or would interfere with study evaluations * Alanine aminotransferase (ALT) or aspartate amino transferase (AST) \>1.2 x ULN; serum creatinine \>ULN; hemoglobin \<12.0 g/dL; other clinical lab tests (with the exception of ALT, AST, serum creatinine and hemoglobin) outside normal or protocol specified limits that are determined by the Investigator to be clinically significant * Use of tobacco or tobacco products * Use of any prescription or nonprescription drugs, vitamins, or dietary supplements within 14 days prior to randomization with the exception of lipid regulating drugs or supplements containing niacin \>500 mg/day or fish oil which will not have been used for 3 months prior to randomization * Other exclusion criteria apply